Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks-Reference-Cited by-同舟云学术

Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks

Published:2014-10 Issue:2 Volume:159 Page:402-414
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Chen James C.,Alvarez Mariano J.,Talos Flaminia,Dhruv Harshil,Rieckhof Gabrielle E.,Iyer Archana,Diefes Kristin L.,Aldape Kenneth,Berens Michael,Shen Michael M.,Califano Andrea

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference38 articles.

1. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy;Aytes;Cancer Cell,2014

2. Reverse engineering of regulatory networks in human B cells;Basso;Nat. Genet.,2005

3. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

4. Leveraging models of cell regulation and GWAS data in integrative network-based association studies;Califano;Nat. Genet.,2012

5. Comprehensive genomic characterization defines human glioblastoma genes and core pathways;Nature,2008

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer;2024-08-26

2. Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs);Cellular & Molecular Biology Letters;2024-03-29

3. The molecular mechanisms of imatinb treatment on acute lung injury in septic mice through proteomic technology;2024-03-19

4. Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease;G3: Genes, Genomes, Genetics;2024-02-27

5. Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma;BMC Medical Genomics;2024-02-08